Vivimed Labs has informed that the Board of Directors at its meeting held on May 27, 2017 has considered and approved the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2017. The Company has informed about Audited Results along with Audit Report and Declaration as per Regulation 33 of the SEBI (LODR) (Amendment) Regulations, 2016; the Board has also recommended, subject to the approval of shareholders, payment of Dividend of Rs 0.40 per equity share of Rs 2 each (20%), to the equity shareholders of the Company for the Financial Year 2016-2017.The said dividend, if approved by shareholders, will be credited /despatched to those members entitled thereto as per record date/Book closure date to be decided subsequently; and the meeting of the Board of Directors of the Company commenced at 2:30 P.M and concluded at 10.00 P.M.
The above information is a part of company’s filings submitted to BSE.
